Studies have shown that upregulation of IL-6 activates STAT3, thereby inhibiting CD8 T-cell infiltration in non-small cell lung cancer and pancreatic cancer [113, 114]. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.